These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20811963)

  • 1. The utility and limitations of FRAX: A US perspective.
    Silverman SL; Calderon AD
    Curr Osteoporos Rep; 2010 Dec; 8(4):192-7. PubMed ID: 20811963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
    Watts NB
    J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture assessment tool risk scores in bone density reports do not change physician prescribing behavior for osteoporosis.
    Izuora KE; Alazraki N; Byrd-Sellers J; Tangpricha V; Nanes MS
    Am J Med Sci; 2011 Jul; 342(1):5-8. PubMed ID: 21412137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" study.
    Anastasilakis AD; Makras P
    Arch Osteoporos; 2020 Oct; 15(1):163. PubMed ID: 33067646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of Fracture Prediction Tools.
    Kanis JA; Harvey NC; Johansson H; Odén A; McCloskey EV; Leslie WD
    J Clin Densitom; 2017; 20(3):444-450. PubMed ID: 28716500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Race/Ethnicity on United States FRAX Calculations and Treatment Qualification: A Registry-Based Study.
    Leslie WD;
    J Bone Miner Res; 2023 Dec; 38(12):1742-1748. PubMed ID: 37548387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of FRAX on the Prediction of Osteoporotic Fractures in Urban Middle-aged and Elderly Healthy Chinese Adults.
    Wang J; Wang X; Fang Z; Lu N; Han L
    Clinics (Sao Paulo); 2017 May; 72(5):289-293. PubMed ID: 28591341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of individual fracture risk: FRAX and beyond.
    van den Bergh JP; van Geel TA; Lems WF; Geusens PP
    Curr Osteoporos Rep; 2010 Sep; 8(3):131-7. PubMed ID: 20563901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies Surrounding the BMD Reporting Standard for the Determination of 10-Year Absolute Fracture Risk: A Canadian Perspective.
    Siminoski K; O'Keeffe M; Akincioglu C; Ganguli SN; Levesque J; Raaphorst P; Tarulli G; Thurston W; Lyons D
    Can Assoc Radiol J; 2021 Aug; 72(3):483-489. PubMed ID: 32162532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
    Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
    Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone quality: educational tools for patients, physicians, and educators.
    Shams J; Spitzer AB; Kennelly AM; Tosi LL
    Clin Orthop Relat Res; 2011 Aug; 469(8):2248-59. PubMed ID: 21400004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions.
    Zerikly R; Demetriou EW
    Womens Health (Lond); 2024; 20():17455057241231387. PubMed ID: 38529935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?
    Hillier TA; Cauley JA; Rizzo JH; Pedula KL; Ensrud KE; Bauer DC; Lui LY; Vesco KK; Black DM; Donaldson MG; Leblanc ES; Cummings SR
    J Bone Miner Res; 2011 Aug; 26(8):1774-82. PubMed ID: 21351144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation and use of FRAX in clinical practice.
    Kanis JA; Hans D; Cooper C; Baim S; Bilezikian JP; Binkley N; Cauley JA; Compston JE; Dawson-Hughes B; El-Hajj Fuleihan G; Johansson H; Leslie WD; Lewiecki EM; Luckey M; Oden A; Papapoulos SE; Poiana C; Rizzoli R; Wahl DA; McCloskey EV;
    Osteoporos Int; 2011 Sep; 22(9):2395-411. PubMed ID: 21779818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
    Ignaszak-Szczepaniak M; Dytfeld J; Michalak M; Gowin E; Horst-Sikorska W
    Ginekol Pol; 2009 Jun; 80(6):424-31. PubMed ID: 19642598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
    Rubin KH; Abrahamsen B; Friis-Holmberg T; Hjelmborg JV; Bech M; Hermann AP; Barkmann R; Glüer CC; Brixen K
    Bone; 2013 Sep; 56(1):16-22. PubMed ID: 23669650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture risk prediction and the decision to treat low bone density.
    Stuckey B; Magraith K; Opie N; Zhu K
    Aust J Gen Pract; 2021 Mar; 50(3):165-170. PubMed ID: 33634286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Vandenput L; Johansson H; McCloskey EV; Liu E; Åkesson KE; Anderson FA; Azagra R; Bager CL; Beaudart C; Bischoff-Ferrari HA; Biver E; Bruyère O; Cauley JA; Center JR; Chapurlat R; Christiansen C; Cooper C; Crandall CJ; Cummings SR; da Silva JAP; Dawson-Hughes B; Diez-Perez A; Dufour AB; Eisman JA; Elders PJM; Ferrari S; Fujita Y; Fujiwara S; Glüer CC; Goldshtein I; Goltzman D; Gudnason V; Hall J; Hans D; Hoff M; Hollick RJ; Huisman M; Iki M; Ish-Shalom S; Jones G; Karlsson MK; Khosla S; Kiel DP; Koh WP; Koromani F; Kotowicz MA; Kröger H; Kwok T; Lamy O; Langhammer A; Larijani B; Lippuner K; Mellström D; Merlijn T; Nordström A; Nordström P; O'Neill TW; Obermayer-Pietsch B; Ohlsson C; Orwoll ES; Pasco JA; Rivadeneira F; Schei B; Schott AM; Shiroma EJ; Siggeirsdottir K; Simonsick EM; Sornay-Rendu E; Sund R; Swart KMA; Szulc P; Tamaki J; Torgerson DJ; van Schoor NM; van Staa TP; Vila J; Wareham NJ; Wright NC; Yoshimura N; Zillikens MC; Zwart M; Harvey NC; Lorentzon M; Leslie WD; Kanis JA
    Osteoporos Int; 2022 Oct; 33(10):2103-2136. PubMed ID: 35639106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.